BEST Inc. — News

RESEARCH TRIANGLE PARK, N.C., July 09, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company”, “Opus Genetics” or “Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today provided updates on its ongoing OPGx-BEST1 Phase 1/2 clinical trial (BIRD-1) targeting BEST-1 associated IRDs.

globenewswire.com - 2026-07-09 07:00:00

FreeCast, Inc. (Nasdaq: CAST), a media technology company providing streaming Platform-as-a-Service (PaaS) solutions, today announced FreeCast Cities™, a new

gurufocus.com - 2026-07-09 07:00:00

CDER meeting expected to take place in the summer of 2026 in parallel with CBER's Type B Statistical Methods Meeting New York, New York and Rockville, Maryland--(Newsfile Corp. - July 8, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that it has accepted a new Meeting Request from the U.S. Food and Drug Administration (FDA)'s Center for Drug Evaluation and Research (CDER) to review the Company's pharmacodynamic response biomarker data (the "OST-HER2 Biomarker Data") – patent pending. CDER's Biomarkers, EndpointS, and other Tools (BEST) resources is part of its Biomarker Qualification Program (BQP).

newsfilecorp.com - 2026-07-08 09:00:00

VANCOUVER, BC, June 26, 2026 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to announce that its common shares have been approved to begin trading today on the OTCQX® Best Market under the ticker symbol "NKGFF". The Company graduates to the premium tier from the OTCQB® Venture Market.

prnewswire.com - 2026-06-26 06:30:00

INDIANA, Pa., June 17, 2026 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp, Inc. (NASDAQ:  STBA ), has been named to the Forbes America's Best-In-State Banks 2026 list, recognizing the financial institutions most valued by customers within their respective states.

prnewswire.com - 2026-06-17 12:19:00

Guests Can Save Big on Tickets, Passes and Summer Adventures at SeaWorld Parks Across the Country for a Limited Time ORLANDO, Fla. and SAN DIEGO and SAN ANTONIO, June 16, 2026 /PRNewswire/ -- In celebration of America's 250th birthday, SeaWorld parks in Orlando, San Diego and San Antonio, as well as Aquatica waterparks in Orlando and San Antonio, are launching the Fourth of July Sale, offering guests the best values of the year on tickets, passes and unforgettable summer experiences.

prnewswire.com - 2026-06-16 10:01:00

Guests Can Save Up to 55% on Tickets, Fun Cards, Passes and Memberships While Enjoying Patriotic Celebrations, Summer Events, New Attractions and Waterpark Fun TAMPA, Fla. and WILLIAMSBURG, Va.

prnewswire.com - 2026-06-16 09:30:00

IRVINE, Calif., May 28, 2026 /PRNewswire/ -- U.S. News & World Report has named four Kia models to its inaugural "Best Adventure Vehicles" awards, highlighting Kia's range of models suited for road trips and outdoor adventures.

prnewswire.com - 2026-05-28 09:00:00

Opus Genetics NASDAQ: IRD is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs already in the clinic and three more expected to enter clinical testing within the next 12 months, President Dr. Ben Yerxa said during a fireside chat at RBC Capital Markets' 2026 Global Healthcare Conference.

marketbeat.com - 2026-05-25 22:02:59

IRVINE, Calif., May 18, 2026 /PRNewswire/ -- Kia's all-new 2027 Telluride X-Pro was named the best three-row family SUV by the Northwest Automotive Press Association (NWAPA) after competing in the association's annual Mudfest event.

prnewswire.com - 2026-05-18 09:00:00

Target Enrollment Achieved with the Inclusion of Participants with Both Dominant and Recessive Forms of BEST Disease Baseline Demographics Presented at ARVO Annual Meeting with Summary Audio and Slide Presentation Available on Opus Website Three-Month Topline Results from Cohort 1 Expected in September 2026 RESEARCH TRIANGLE PARK, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced the completion of enrollment in Cohort 1 of its ongoing Phase 1/2 study of OPGx-BEST1 gene therapy.

globenewswire.com - 2026-05-07 07:00:00

2027 Telluride HEV recognized as Best Midsize Hybrid SUV 2026 Niro HEV named Best Subcompact Hybrid SUV 2026 Sportage PHEV awarded Best Compact Plug-in Hybrid SUV IRVINE, Calif., April 24, 2026 /PRNewswire/ -- U.S. News & World Report has named three Kia vehicles to its "Best Hybrid and Electric Car" annual awards program.

prnewswire.com - 2026-04-24 15:17:00